GLP-1 weight drug side effects create new beauty and nutrition market

Indian companies are racing to launch protein-rich foods, collagen supplements and face fillers to capitalise on side effects from the growing use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro.

Indian companies are racing to launch protein-rich foods, collagen supplements and face fillers to capitalise on side effects from the growing use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro.

GLP-1 weight-loss drugs spark new India market for side-effect products

Rapid weight loss from these prescription medicines depletes facial volume, skin elasticity, and protein and fibre levels, creating new demand in both nutrition and beauty. Nestle India, through its joint venture with Dr. Reddy's Laboratories, has introduced Celevida GLP+, a nutrition supplement for people on GLP-1 therapy. Tata Consumer Products is preparing to enter waters and snacks with protein and fibre, with managing director Sunil D'Souza saying the company will start launching products across multiple categories in the next 60 days.

Sugar Cosmetics and HUL's Lakme are promoting non-invasive make-up alternatives such as lip fillers. Radhika Ghai, founder of Kindlife, called this demand the biggest new driver beauty has had in a decade, growing with the patient base rather than fading seasonally.

Indian Opinion Analysis

The coverage is uniform straight business reporting, with both outlets using identical quotes and information. The story is a classic demand-shift tale: GLP-1 drugs create side effects, which create a new consumer market. The measured middle-ground read is that this is a real market signal, Tata and Nestle's joint venture with Dr. Reddy's are concrete moves, but the market is nascent and the consumer base tied to prescription growth. Sugar Cosmetics and Lakme's 'lip fillers' are non-invasive make-up, not medical procedures, a nuance easy to overstate. Watch the next 60 days for Tata's product launch.

Coverage: 2 sources, 2 neutral


Sources (2): economictimes.indiatimes.com (neutral report), timesofindia.indiatimes.com (neutral report)

This story was synthesised by AI from the 2 sources linked above.

Updated: this story now draws on 2 sources.

Ask their opinion on this story
They have read this article, our coverage, and the web.
AI simulations of historical figures. Responses are generated from the historical record, not authentic statements.

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Share your opinion

Loading Next Post...
Search Trending
Ask their opinion
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...

All fields are required.